We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Mechanotransduction Device Treats Small Bowel Syndrome

By HospiMedica International staff writers
Posted on 05 Jan 2022
Print article
Image: The Eclipse XL1 placed inside the shortened small bowel (Photo courtesy of Eclipse Regenesis)
Image: The Eclipse XL1 placed inside the shortened small bowel (Photo courtesy of Eclipse Regenesis)
A prototype spring-like device applies controlled force to expand healthy tissue in patients suffering from short bowel syndrome (SBS).

The Eclipse Regenesis (Menlo Park, CA, USA) XL1 is a small, compressed coil that is placed inside the small intestine, secured at both ends with plication sutures. The natural expansion and contraction of the intestine work against the resistance of the device, leading to a mechanical transduction that stretches the bowel. Over a two to three week period, the compressed coil device slowly expands to its relaxed state, stimulating new tissue growth in the treated segment, and ultimately expanding it to two to three times the segment’s original length (about four cm).

Once the process is complete, the chromic sutures dissolve, allowing the XL1 to pass through the body to be excreted. Treatment length varies, depending on the starting point (amount of small intestine), the end point (how much new intestine is needed) needed to reduce total parenteral nutrition dependence. Preclinical studies show successful lengthening of the bowel, no perforations, and no obstructions. The newly formed tissue looks and acts like normal intestinal tissue with regard to metabolic uptake and contractile function.

“The basic concept is similar to distraction osteogenesis, which orthopedic surgeons have used for years, applying distraction force to broken bone that will grow up to a millimeter a day,” said Andre Bessette, CEO and a co-founder of Eclipse Regenesis. “Patients with SBS have lost more than 50% of their small intestine, so they’ll need more than one device applied or more than one procedure. We are getting close to performing the first-in-human procedure, and we hope to eventually be able to perform this procedure completely endoscopically.”

SBS is a devastating condition where patients struggle to absorb life-sustaining nutrients from their diet. It typically results from intestinal resection due to necrotizing enterocolitis (NEC), which takes place when the lining of the intestinal wall becomes infected and dies. It can also result from birth defects, such as Gastroschisis, Volvulus, Hirschsprung’s Disease, Intestinal Atresia, and other congenital defects. Patients struggle to absorb life-sustaining nutrients from their diet, and many become reliant on total parenteral nutrition (TPN) to survive.

Related Links:
Eclipse Regenesis

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Neonatal Ventilator
Servo-n

Print article

Channels

Critical Care

view channel
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.